WEDNESDAY, SEPTEMBER 28, 2016

New computer models predict patient response to HIV drug therapy

HIV Read More »

Project launches to rapidly deliver data on vaccines

A new five-year project will bring together multiple organizations from the private and public sectors to improve benefit and risk assessments of vaccines, the European Centre for Disease Prevention and Control recently announced. Read More »

ECDC reports rate of HIV infection increased by 8 percent in 2012

The European Centre for Disease Prevention and Control and the World Health Organization said on Wednesday that new cases of HIV infection increased by 8 percent in the WHO European Region in 2012. Read More »

WHO reports three new MERS-CoV cases and two deaths

MERS CoV Read More »

Children in Philippines receive vaccines against polio, measles

More than 30,000 children are being targeted as part of a vaccination campaign in Tacloban, Philippines, the city hit hardest by Typhoon Haiyan, the World Health Organization recently announced. Read More »

FDA approves GlaxoSmithKline avian flu vaccine

The U.S. Food and Drug Administration recently approved a pandemic influenza vaccine manufactured by GlaxoSmithKline, which could increase pandemic preparedness, according to the U.S. Department of Health and Human Services. Read More »

MRSA cases increase by 20 percent in 2012

MRSA Read More »

(RED) raises $46 million at auction to fight HIV/AIDS

(RED) raised $46 million total for the Global Fund's fight against AIDS with the help of activists and partners at an auction on November 23. Read More »

South African grants reduce HIV risks for teen girls

HIV Read More »

Pneumococcal conjugate vaccine reduces number of ear infections

Streptococcus pneumonia Read More »

Phase 2 clinical trials for InnaVirVax therapeutic HIV vaccine begin

InnaVirVax SA said on Sunday that it will begin Phase 2 clinical trials of the VAC-3S vaccine as part of treatment for HIV-1 infection. Read More »

U.N. and partners roll out immunization campaign in Philippines

The United Nations Children's Fund, the World Health Organization, The Philippine Department of Health and partners announced on Nov. 27 the rollout of a national vaccination program to vaccinate more than 30,000 children. Read More »

Novartis discovers new malaria drug target

Scientists with Novartis, a Basel, Switzerland-based pharmaceutical company, found a new drug target for treating malaria that could result in a treatment for multiple stages of the deadly disease, Novartis said on Thursday. Read More »

PharmAthene terminates merger agreement with Theraclone

PharmAthene, Inc., an Annapolis, Maryland-based biodefense company, announced on Monday that it terminated its definitive merger agreement with Theraclone Sciences, Inc., a Seattle-based antibody development company, with Theraclone's consent. Read More »

FDA study helps explain rising rates of whooping cough

Pertussis Read More »

UNICEF calls for support to end adolescent HIV infection

The United Nations Children's Fund released a recent report calling for an acceleration of access to HIV treatment and prevention methods to aid adolescents living with HIV around the world. Read More »

HIV patients receiving treatment from Global Fund on the rise

The number of people being treated for HIV by the Global Fund to Fight AIDS, Tuberculosis and Malaria rose significantly in the last six months, the Global Fund recently reported. Read More »

Significant challenges remain to defeat AIDS

HIV Read More »

Nanosponge vaccine fights MRSA toxin

MRSA Read More »

Novartis launches new strategy to eradicate leprosy

The Novartis Foundation for Sustainable Development announced a new strategy to eradicate leprosy once and for all on Friday at a symposium on disease elimination. Read More »